2Stenunermann G, Heffelfinger SC, Noffsinger A, et al. The molecular biology of esophageal and gastric cancer and their precursors:oncogenes, tumor suppressor genes and growth factors[J]. Hum Pathol,1994,25:968.
3Musto P. High risk of early resistance relaps for leukemic patients with presence of multidrug resistance assosiated glycoprotein positive cells in complete remission[J]. Br J Haematol, 1991,77:50 .
4Levin A J, Momand J. Finlay CA. The p53 tumor suppressor gene[J]. Nature, 1991,351:453.
5Parenti AR, Rugge M, Frizzera E, et al. p53 overexpression in the multistep process of esophageal carcinogenesis[J]. Am J SurgPathol, 1995,19:1418.
7MM Gottesman.How cancer cells evade chemotherapy: sixteenth Richard and Hinda Rosenthal Foundation Award Lecture.Cancer Res, 1993, 53(4): 747-754
8W Cao, X Chen, H Dai, et al.Mutational spectra of p53 in geographically localized esophageal squamous cell carcinoma groups in China.Cancer, 2004, 101(4): 834-844
9Chin KV, Ueda K, Pastan I, et al.Modulation of activity of the promoter of the human MDR1 gene by Ras and p53.Science, 1992, 255(5043): 459-462
10Bahr, W.Wick, M.Weller.Modulation of MDR/MRP by wild-type and mutant p53.J.Clin.Invest, 2001, 107(5): 643-645
